Inventor-led development of a graded sodium hyaluronate-glucosamine-chondroitin-MSM composition for synovitis control and cartilage microenvironment support
Gregg L.Semenza
World Food Supplement Association
Jabar Yassine
World Food Supplement Association
Paul Becker
World Food Supplement Association
DOI: https://doi.org/10.59429/pest.v8i2.14481
Keywords: synovitis; cartilage microenvironment; glucosamine hydrochloride; chondroitin sulfate; MSM; sodium hyaluronate; HIF; translational formulation
Abstract
We present a lesion-oriented oral joint-support composition built around glucosamine hydrochloride, chondroitin sulfate, methylsulfonylmethane (MSM), and graded sodium hyaluronate. Its distinctiveness is evaluated through formulation architecture and evidence rather than naming alone. The central design feature is the use of high-molecular-weight sodium hyaluronate for lubrication and local film formation together with medium/low-molecular-weight material for penetration and ingredient coexistence. In the preclinical dataset, optimized formulations achieved substantially higher joint-effusion resolution and cartilage-repair rates than the comparative formulation. Public evidence for the component ingredients is heterogeneous but directionally supportive: Glucosamine/chondroitin shows mixed benefit across reviews, MSM has shown symptom-related benefit in controlled trials, and oral sodium hyaluronate has demonstrated short-term improvement in selected knee-discomfort populations. We therefore interpret the composition as more than a routine joint-health blend because it organizes familiar ingredients into a graded residence-penetration-microenvironment support system.
References
[1] Nobel Prize Outreach. The Nobel Prize in Physiology or Medicine 2019. NobelPrize.org. Accessed 28 Mar 2026.
[2] Chen B, et al. Role of crosstalk between synovial cells and chondrocytes in osteoarthritis. Exp Ther Med. 2024.
[3] Arai Y, et al. Cartilage homeostasis under physioxia. Int J Mol Sci. 2024.
[4] Zeng CY, et al. HIF-1alpha in osteoarthritis: from pathogenesis to therapeutic implications. Front Pharmacol. 2022.
[5] Meng Z, Sang L, Wu D, Rong J, Jiang L. Efficacy and safety of the combination of glucosamine and chondroitin for knee osteoarthritis: a systematic review and meta-analysis. Eur J Med Res. 2023.
[6] Baden KER, et al. The safety and efficacy of glucosamine and/or chondroitin in humans: a systematic review. Nutrients. 2025.
[7] Roman-Blas JA, et al. Combined treatment with chondroitin sulfate and glucosamine sulfate shows no superiority over placebo for reduction of joint pain and functional impairment in patients with knee osteoarthritis. Arthritis Rheumatol. 2017.
[8] Kim LS, Axelrod LJ, Howard P, Buratovich N, Waters RF. Efficacy of methylsulfonylmethane in osteoarthritis pain of the knee: a pilot clinical trial. Osteoarthritis Cartilage. 2006.
[9] Toguchi A, et al. Methylsulfonylmethane improves knee quality of life in participants with mild knee pain: a randomized, double-blind, placebo-controlled trial. Nutrients. 2023.
[10] Cicero AFG, et al. Short-term effect of a new oral sodium hyaluronate formulation on knee osteoarthritis: a double-blind, randomized, placebo-controlled clinical trial. Clin Med Insights Arthritis Musculoskelet Disord. 2020.
[11] Lu KH, Lu PWA, Lin CW, Lu EWH, Yang SF. Different molecular weights of hyaluronan research in knee osteoarthritis: a state-of-the-art review. Matrix Biol. 2023.